Mission Creek Capital Partners, Inc. Recursion Pharmaceuticals, Inc. Transaction History

Mission Creek Capital Partners, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 13, 2022	SELL	$6.16 - $18.03 $688,996 - $2.02 Million	-111,850 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$16.14 - $21.86 $1.81 Million - $2.45 Million	111,850 New	111,850 $1.92 Million

286

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.38B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Mission Creek Capital Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Mission Creek Capital Partners, Inc. with notifications on news.